Direktorat Registrasi ObatValid

CETIRIZINE

by '-'

BPOM Number: GKL1007119810A1
Approved: 9 January 2025
Expiry: 5 April 2025
Form: Tablet

About This Registration

CETIRIZINE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1007119810A1. Its current registration status is Valid, with the licence valid until 5 April 2025. The product is registered to PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA. BPOM first approved this registration in April 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 3 STRIP @ 10 TABLET
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA
KAB. SIDOARJO
NPWP: 011221314641000
owner
View profile →

Manufacturing Sites

PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA
KAB. SIDOARJO
primary
View profile →

Market Intelligence

Owner Portfolio: PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA holds 101 BPOM registrations
Manufacturer Scale: PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA produces 101 registered products
Registration Age: Registered for 5 years, 5 months
Expiry Status: Expired 540 days ago

FDA Cross-Reference

via openFDA

Generic Name: CETIRIZINE HYDROCHLORIDE
Product Type: HUMAN OTC DRUG
Route of Administration: ORAL
Purpose: Purpose Antihistamine

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?